(57) NF1 regulates the RTK/Ras/PI3K signaling pathway, and mutations in this gene lead to loss of function, which promotes cellular transformation and drives the transition of glioma cells towards a more aggressive, mesenchymal phenotype. This evidence concerns the gene NF1 and central nervous system cancer.